CareDx, Inc. (CDNA) Q3 2026 earnings results
CareDx, Inc. (CDNA) reported Q3 2026 results on Oct 29, 2026, 4:02:34 PM ET: GAAP EPS $0.35 vs. $0.26 expected (beat by 37.3%); revenue $139.36M vs. $121.96M expected (beat by 14.3%). Outlook: Full year 2026 revenue guidance raised to $520 million to $530 million and Adjusted EBITDA to $90 million to $100 million.
| Metric | Reported | Analyst estimate | Result |
|---|---|---|---|
| EPS (GAAP, diluted) | $0.35 | $0.26 | Beat by 37.3% |
| Revenue | $139.36M | $121.96M | Beat by 14.3% |
Analyst estimate: the average forecast before the release.
Source
Figures from the SEC 8-K filing, released Oct 29, 2026, 4:02:34 PM ET. Nexqual published them 35 seconds after release. Each figure is confirmed by two independent extraction methods before it is published.
Year over year
Compared with the same quarter a year earlier (ended September 30, 2025, from the company's SEC filing): revenue grew 39.3% from $100.06M; GAAP diluted EPS was $0.35 vs. $0.03.
Stock reaction
The results came out after the market closed. CDNA closed at $71.52 on October 29, 2026, before the results. The first trading session after the release is Friday, October 30, 2026; this page shows the reaction once trading starts (pre-market and after-hours prices are not included).
Questions and answers
Did CareDx, Inc. beat earnings expectations?
Yes. CareDx, Inc. reported GAAP EPS of $0.35 against an average analyst estimate of $0.26 (beat by 37.3%), and revenue of $139.36M against $121.96M expected (beat by 14.3%).
What were CareDx, Inc.'s Q3 2026 earnings and revenue?
GAAP diluted EPS of $0.35 and revenue of $139.36M. Compared with the same quarter a year earlier (ended September 30, 2025, from the company's SEC filing): revenue grew 39.3% from $100.06M; GAAP diluted EPS was $0.35 vs. $0.03.
When did CareDx, Inc. report Q3 2026 earnings?
Oct 29, 2026, 4:02:34 PM ET, in an SEC 8-K filing (Item 2.02).
How did CDNA stock react to the earnings?
The results came out after the market closed. CDNA closed at $71.52 on October 29, 2026, before the results. The first trading session after the release is Friday, October 30, 2026; this page shows the reaction once trading starts (pre-market and after-hours prices are not included).
What did CareDx, Inc. say about its outlook?
Full year 2026 revenue guidance raised to $520 million to $530 million and Adjusted EBITDA to $90 million to $100 million.
More on CDNA
CDNA stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. All results reported that day: earnings October 29, 2026.
Source: SEC EDGAR 8-K (Item 2.02), Nexqual Earnings Flash. Built October 29, 2026 at 23:07 UTC. Not investment advice.
Data source: Nexqual. Last updated: October 29, 2026 at 23:07 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt